GLP-1 agonists such as semaglutide act through GLP-1 receptors, whereas cagrilintide acts through amylin/calcitonin receptors in the hindbrain area postrema, sending a vagal signal that decelerates the stomach
Many patients obtain these medications outside traditional health care settings or from providers outside your network
Matches Phase III exposure
In the Phase 3 trials, nausea was reported by approximately 44% of patients on Wegovy (semaglutide 2.4 mg) and approximately 28% of patients on Zepbound (tirzepatide 15 mg) during dose titration, usually mild to moderate, and usually improving with time and dose stabilization
Anecdotal evidence suggests significant changes in body composition become apparent within this timeframe
Freckles, I gained 20+ more of them, Ive always had them so it isnt an issue, some people dont like freckles